Hrt Financial »

Acrivon Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $18k 10k 1.74
2025-06-30 $173k 146k 1.19

More positions owned by Hrt Financial

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl C (GOOG)
Bloom Energy Corp Com Cl A (BE)
Advanced Micro Devices Put
Space Exploration Techn Corp Class A Com Stk (SPCX)
Micron Technology Put
Ishares Tr Call
Advanced Micro Devices (AMD)
Ishares Tr Call
Nvidia Corporation Put
Micron Technology (MU)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Oracle Corporation (ORCL)

View all positions for Hrt Financial

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Acadian Asset Management
Vanguard Capital Management
Wellington Management Company
Renaissance Technologies
Two Sigma Investments
Marshall Wace
Bridgeway Capital Management
Geode Capital Management
BlackRock
GSA Capital Partners
Vanguard Fiduciary Trust
XTX Topco
Jane Street

View all funds holding Acrivon Therapeutics